Work

Multifaceted Burden of Chronic Graft-versus-Host Disease

Year: 2018

Type: article

Abstract: Curative therapies can leave a lasting burden on cancer patients. Survivorship issues are becoming a “pandemic of treatment success” and include not only short- and long-term treatment side effects, development of subsequent cancers, and psychosocial issues but also a lasting financial toll [1]. It is increasingly recognized that cancer survivorship is tightly associated with a decline in financial health and the unavoidable impact of high associated medical care costs extending beyond those accrued during the initial treatment [2,3].

Source: Transplantation and Cellular Therapy

DOI: 10.1016/j.bbmt.2018.07.012

Authors: Vedran Radojcic, Catherine J. Lee, Daniel R. Couriel

Institutions: Huntsman Cancer Institute, University of Utah

Language: English

Topic: Hematopoietic Stem Cell Transplantation

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,650